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BACKGROUND
India is committed to achieving the goals of Family Planning 
2020 (FP2020), which, besides substantially increasing new 
contraceptive users, also demands adopting a rights-based 
approach and ensuring easy access, choice and good quality 
services. In the process of increasing contraceptive use. The 
contraceptive method mix in India has been dominated by 
female sterilization for a long time. No new contraceptive 
method has been added to the national family welfare 
program for decades. The Drugs Controller General of India 
(DCGI) has approved use of injectable contraceptives in 1994 
from the private sector, but still it is not part of the national 
program.
Recently some initiatives have been taken to make Depo 
Medroxyprogesterone Acetate (DMPA) available through the 
public sector in some parts of the country. Two such initiatives 
that are well known include (a) Urban Health Initiative (UHI) 
project of FHI360 funded by the Bill and Melinda Gates 
Foundation (BMGF) which was implemented in public as well 
as private health facilities of 11 towns of Uttar Pradesh (UP), 
(b) an initiative taken up by the District Collector of 
Rajsamand district in Rajasthan, who encouraged district 
health officials to introduce DMPA in all rural public health 
facilities in the district like Community Health Centers (CHCs), 
Primary Health Centers (PHCs) and some of the active Sub-
cente Rs. 
The public facilities in UP that participated in the UHI initiative 
included DMPA while counseling FP clients on the various 
contraceptive methods available in the facility. The counselors 
and doctors were oriented by UHI on DMPA. The facilities did 
not stock DMPA but it was prescribed to women who desired 
to take DMPA and if she came back with the injection the 
doctor or the public health nurse of the facility administrated 
it. The community mobilization of women living in poor 
localities and slums was done by local Non-Governmental 
Organizations (NGOs) partnering with UHI in educational and 
motivational effort for adopting contraceptive methods. The 
NGOs had hired peer educators, each of them responsible for 
two thousand population, to promote contraceptives among 
couples in reproductive age. The NGO, Janani, partnered with 
UHI, organized fixed day clinics at selected spots, where a 
doctor and a public health nurse provided the services. 
In Rajsamand district, before introducing DMPA, all the 
doctors and Lady Health Visitors/Auxiliary Nurse Midwifes/ 
Public Health Nurses (LHVs/ANMs/PHNs) were trained at the 
district headquarter by district officials and a consultant form 
Population Health Services India (PHSI), the social marketing 
agency and promoter of Khushi brand of DMPA. The LHVs 
gave half-day orientation to Accredited Social Health Activists 
(ASHAs) on DMPA. The district authorities use their 
unrestricted fund to purchase DMPA in bulk at a negotiated 
price of Rs. 28 (US$ 0.40) per dose from PHSI. The CHCs and 
PHCs purchase DMPA from the district public store as per 
their need and charge their clients Rs. 30 (US$ 0.50) per 
dose. Thus recovering the unrestricted fund for continued 
purchase of DMPA. Initially DMPA was provided only at CHCs 
and PHCs and was mostly administrated by LHVs/PHNs. Later, 
considering the difficulties faced by women in traveling, DMPA 
was made available on a fixed day of the week at some of the 
well established Sub-centers and administered by ANM. 
Initially it was done under the supervision of LHVs of the area. 
Present study was undertaken to document these initiatives 
taken to provide DMPA through public health facilities, which 
in a way could be taken as feasibility study or initial phase of 
introducing DMPA in the public sector. 
A multistage sampling procedure was followed and total of 
624 DMPA ever users, 316 from three cities of UP (Allahabad, 
Lucknow and Aligarh) and 308 from rural areas of Rajsamand 
district were interviewed with informed consent obtained from 
each of the participants. The sample was sufficient to provide 
a statistical valid estimate of responses on the subject. 
Besides, in-depth interviews were also conducted with nine 
women to get their perspectives on using DMPA. To get 
previdus perspectives 38 doctors and 58 paramedics 
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(LHVs/Nurses/ ANMs) from 21 public health facilities of 
Rajsamand and 15 public health facilities of UP were also 
interviewed. Additionally, 55 CHWs (33 ASHAs from 
Rajsamand and 22 peer educators/counselors from UP) were 
also interviewed. 
The study revealed that young married women (mean age of 
27 years) were using DMPA for spacing births. The reasons for 
women to choose DMPA over other methods are given in 
Table 1. About 21 percent women had adopted DMPA after 
first child and 18 percent did not have a son. It is perhaps 
because of increased access to additional and long acting 
spacing method besides IUCD. In the Indian family planning 
program spacing methods were less promoted than limiting 
methods as indicated by a low use of IUD and other temporary 
methods compared to female sterilization. Use of DMPA for 
spacing births was more in Rajsamand than UP. This is partly 
because, in Rajsamand DMPA was suggested for spacing 
while sterilization was suggested to those women who have 
achieved their desired family size. 
The following gives a typical quote that was mentioned by 
several users revealing factors influencing decision to use 
DMPA.
“I used to forget to take pills. I heard that condom 
remains inside. So I decided to try injection. The 
advantage of injection is that after taking it you need not 
take anything for three months. Injection suits me. The 
other advantage is that nobody knows about it.” (Woman, 
24 years, 3 children, 2 doses, Aligarh, UP)
The study shows that overall women as well as other 
stakeholders had positive opinion about DMPA. Out of the 624 
ever users of DMPA interviewed, about 31 percent were 
current use Rs. Discontinuation was high because of side 
KEY FINDINGS
*Multiple responses, add up to more than 100.
TABLE 1: Women's reasons for choosing DMPA over other 
contraceptive methods (percent)*
Reasons UP Rajsamand Total
                                 Total (N) 316 308 624
Private & confidential 22 21 21
Nothing to be done daily 45 63 54
Easy to use 39 27 33
Easily available 10 16 13
Effective/reliable/safe 31 30 30
Peer educator/friends advice 40 3 22
Doctors advised 5 0 3
Affordable 5 7 6
Other 12 22 17
effects. Analysis revealed that discontinuation by second dose 
was more than 50 percent both in UP and Rajsamand. The 
study also revealed that among the current users of DMPA, 41 
percent (and 13 percent among 624 ever user) had taken four 
or more doses. The corresponding figure (Figure 1) was 
52 percent in UP and 34  in Rajsamand. 
This is perhaps because of better follow up of first and second 
dose acceptors of DMPA were motivated by peer educators in 
UP than ASHAs in Rajsamand. The helpline, called ‘Careline’, 
operated by Abt Associates also counselled women, which 
encouraged them to continue using DMPA (Figure 2).
“I did not find any major problem except that my periods 
have been stopped and I gain weight.” (Woman, 24 years, 
2 children, 6 doses, Aligarh, UP)
“Those women who don’t have any problems from Depo 
and those who want to space births take 3 or more 
doses. But women who face side effects or their 
husbands find out, or they want more children stop using 
it.” (ASHA, Rajsamand, Rajasthan)
Figure 2 shows most women believed that DMPA is a safe (75 
to 80 percent) and effective contraceptive method (90 
percent in both study sites). They also believed that DMPA is a 
good long acting contraceptive method (about 80 percent in 
the two sites) for spacing births. Women chose DMPA over 
other spacing methods as it saves them from daily 
administration of a contraceptive and once taken they do not 
have to worry about protection for three months. The 
knowledge of interval between two doses was universal. About 
half of the women had knowledge about the grace period if 
they missed their due date. One-third women (27 percent in 
UP and 33 percent in Rajsamand) did not know how long 
DMPA could be used continuously. About half the women did 
not know about return of fertility after discontinuation.
Quality of services was generally good. At all service delivery 
points in both study sites women were given options of 
different contraceptive methods to choose from and provider 
bias towards DMPA was not found. However, in UP, where the 
peer educators were getting incentive for motivating IUD, 
DMPA and sterilization, these methods were mentioned more 
frequently during counseling than other methods. 
percent
“Peer educator has told me about all the methods, 
Copper T, pills, condom” (Woman, 23 years, 3 children, 
15 doses, Allahabad, UP).
It is important however to note that about half the women 
were not told about the side effects indicating improvement in 
counseling. 
Cost was an issue for more than half of the women, 
particularly for those women who faced side effects. In some 
cases cost of treatment from side effects was more than the 
DMPA. In Rajsamand, cost of the DMPA was lower (Rs. 30, 
US$ 0.50) than UP (Rs. 55 to 65, US$ 0.90 to 1) and majority 
of the women felt that it could be affordable to most women in 
their community. The study revealed that in Rajsamand, 
current price of DMPA i.e. Rs. 30 was acceptable to 92 
percent of the women so they expressed their willingness to 
pay for DMPA. About 73 percent of all the women interviewed 
felt that up to Rs. 40, US$ 0.60 is an acceptable price. More 
than half of the participants said that they would not be able 
to pay if the price of DMPA is more than Rs. 65. Therefore, 
increasing the price beyond Rs. 65 could lead to drastic 
decline in DMPA use. A similar analysis for UP revealed that 
current price (Rs. 55-65) was affordable to most (82%) and an 
increase up to Rs. 75, US$ 1.20 would be manageable for 67 
percent of the women. Only about 45 percent felt that they 
would be willing to pay Rs. 100, US$ 1.60 or more. Overall, 
the study indicates that the maximum cost for rural area could 
be Rs. 40 and in rural poor localities and in urban slum areas 
it could range between Rs. 90 to 100 (US$ 1.40 to 1.60).
Figure 2: Women's knowledge and beliefs on DMPA
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Figure 3: Quality of counseling and care 
received by women
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Figure 1: Number of doses taken among current
users of DMPA
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Interviews of the program managers, doctors, paramedics, 
and community health workers showed that just as the 
beneficiary had expressed, most provide (90 to 95 percent) 
strongly felt that DMPA has provided a good additional 
contraceptive choice to women. Two-third of doctors and 
paramedics strongly supported that DMPA should be included 
in the national family welfare program because it is long 
acting method and once given women do not have to worry for 
three months (53 percent doctors and 74 percent 
paramedics), besides they felt that DMPA is safe (25 to 30 
percent), easily administered (38 percent doctors and 23 
percent paramedics), and keeps contraceptive status 
confidential (17 percent doctors and 29 percent paramedics) 
(Table 2). Practically all of them were of the view that the 
existing amount (Rs. 30 in Rajsamand and about Rs. 65 in 
UP) is affordable.
The study shows that acceptability of the DMPA has 
remained good despite many women reporting side 
effects. It indicates that DMPA could be introduced safely 
without serious health consequences in public sector.
Most stakeholders, doctors, and paramedics including the 
beneficiary feel that it should be included in the national 
family welfare program. 
A supportive environment to introduce DMPA in the public 
sector is needed. It could be created if FOGSI, IMA and 
similar medical associations are taken into confidence. 
DMPA will be an additional long acting contraceptive 
choice to women willing to space between births and do 
not want to use IUD or other spacing methods. 
At the initial stages government may plan to introduce 
DMPA at district health facilities and CHCs and then 
expand to PHCs and Sub-cente Rs. 
Like in Rajsamand DMPA could be provided at a cost in 
public sector. A cost of Rs. 30 to 40 in rural area and Rs. 
60 to 100 in urban facilities could be charged. Women are 
willing to pay that if they are made aware of the method 
and made easily accessible. 
Counseling and follow up are important measures to 
promote continuation of DMPA use. Women who use 5 to 6 
doses may achieve a minimum desired gap of 3 years 
between two births. 
Presently up to 50 percent women are dropping out after 
ndthe 2  dose of DMPA. This indicates that more studies are 
required on how to reduce discontinuation rate of DMPA 
due to side effects and other myths about the method. 
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*Multiple responses, add up to more than 100.
TABLE 2:  Attitudes of doctors and nurses (percent)
Attitudes Doctors Nurses  
(N=38) (N=58)
Agree that DMPA has provided a 90 95
good choice 
Strongly recommended to include 66 64
in NFWP
Key reasons to include in NFWP*
Safe to use 25 30
Effective 13 13
Long acting 53 84
Easy to administer/easy to use 38 23
Private & confidential 16 29
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